Advertisement
Journal of Investigative Dermatology Home

Targeting the Human βc Receptor Inhibits Contact Dermatitis in a Transgenic Mouse Model

Published:September 16, 2021DOI:https://doi.org/10.1016/j.jid.2021.07.183
      Allergic contact dermatitis (ACD) is a prevalent and poorly controlled inflammatory disease caused by skin infiltration of T cells and granulocytes. The beta common (βc) cytokines GM-CSF, IL-3, and IL-5 are powerful regulators of granulocyte function that signal through their common receptor subunit βc, a property that has made βc an attractive target to simultaneously inhibit these cytokines. However, the species specificity of βc has precluded testing of inhibitors of human βc in mouse models. To overcome this problem, we developed a human βc receptor transgenic mouse strain with a hematopoietic cell‒specific expression of human βc instead of mouse βc. Human βc receptor transgenic cells responded to mouse GM-CSF and IL-5 but not to IL-3 in vitro and developed tissue pathology and cellular inflammation comparable with those in wild-type mice in a model of ACD. Similarly, Il3–/– mice developed ACD pathology comparable with that of wild-type mice. Importantly, the blocking anti–human βc antibody CSL311 strongly suppressed ear pinna thickening and histopathological changes typical of ACD and reduced accumulation of neutrophils, mast cells, and eosinophils in the skin. These results show that GM-CSF and IL-5 but not IL-3 are major mediators of ACD and define the human βc receptor transgenic mouse as a unique platform to test the inhibitors of βc in vivo.

      Abbreviations:

      ACD (allergic contact dermatitis), CHS (contact hypersensitivity), hβc (human βc), hβcTg (human βc receptor transgenic), STAT5 (signal transducer and activator of transcription 5), WT (wild type), βc (beta common)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'
      Society Members (SID/ESDR), remember to log in for access.

      Subscribe:

      Subscribe to Journal of Investigative Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Asquith K.L.
        • Ramshaw H.S.
        • Hansbro P.M.
        • Beagley K.W.
        • Lopez A.F.
        • Foster P.S.
        The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation.
        J Immunol. 2008; 180: 1199-1206
        • Becher B.
        • Tugues S.
        • Greter M.
        GM-CSF: from growth factor to central mediator of tissue inflammation.
        Immunity. 2016; 45: 963-973
        • Broughton S.E.
        • Dhagat U.
        • Hercus T.R.
        • Nero T.L.
        • Grimbaldeston M.A.
        • Bonder C.S.
        • et al.
        The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.
        Immunol Rev. 2012; 250: 277-302
        • Dougan M.
        • Dranoff G.
        • Dougan S.K.
        GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation.
        Immunity. 2019; 50: 796-811
        • Dudeck A.
        • Dudeck J.
        • Scholten J.
        • Petzold A.
        • Surianarayanan S.
        • Köhler A.
        • et al.
        Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.
        Immunity. 2011; 34: 973-984
        • Gillessen S.
        • Mach N.
        • Small C.
        • Mihm M.
        • Dranoff G.
        Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity.
        Blood. 2001; 97: 922-928
        • Grimbaldeston M.A.
        • Nakae S.
        • Kalesnikoff J.
        • Tsai M.
        • Galli S.J.
        Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.
        Nat Immunol. 2007; 8: 1095-1104
        • Guthridge M.A.
        • Stomski F.C.
        • Thomas D.
        • Woodcock J.M.
        • Bagley C.J.
        • Berndt M.C.
        • et al.
        Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors.
        Stem Cells. 1998; 16: 301-313
        • Hamilton J.A.
        GM-CSF in inflammation.
        J Exp Med. 2020; 217e20190945
        • Hara T.
        • Miyajima A.
        Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3).
        EMBO J. 1992; 11: 1875-1884
        • Honda T.
        • Egawa G.
        • Grabbe S.
        • Kabashima K.
        Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis.
        J Invest Dermatol. 2013; 133: 303-315
        • Itakura A.
        • Kikuchi Y.
        • Kouro T.
        • Ikutani M.
        • Takaki S.
        • Askenase P.W.
        • et al.
        Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells.
        Int Arch Allergy Immunol. 2006; 140: 8-16
        • Jeong C.W.
        • Ahn K.S.
        • Rho N.K.
        • Park Y.D.
        • Lee D.Y.
        • Lee J.H.
        • et al.
        Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR.
        Clin Exp Allergy. 2003; 33: 1717-1724
        • Kaplan D.H.
        • Igyártó B.Z.
        • Gaspari A.A.
        Early immune events in the induction of allergic contact dermatitis.
        Nat Rev Immunol. 2012; 12: 114-124
        • Kobayashi M.
        • Nunomura S.
        • Gon Y.
        • Endo D.
        • Kishiro S.
        • Fukunaga M.
        • et al.
        Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone.
        J Invest Dermatol. 2010; 130: 725-731
        • Lantz C.S.
        • Boesiger J.
        • Song C.H.
        • Mach N.
        • Kobayashi T.
        • Mulligan R.C.
        • et al.
        Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites.
        Nature. 1998; 392: 90-93
        • Lutz M.B.
        • Strobl H.
        • Schuler G.
        • Romani N.
        GM-CSF monocyte-derived cells and Langerhans cells as part of the dendritic cell family.
        Front Immunol. 2017; 8: 1388
        • Mach N.
        • Lantz C.S.
        • Galli S.J.
        • Reznikoff G.
        • Mihm M.
        • Small C.
        • et al.
        Involvement of interleukin-3 in delayed-type hypersensitivity.
        Blood. 1998; 91: 778-783
        • Martin S.F.
        • Rustemeyer T.
        • Thyssen J.P.
        Recent advances in understanding and managing contact dermatitis.
        F1000Res. 2018; 7: F1000
        • Martinez-Moczygemba M.
        • Huston D.P.
        Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF.
        J Allergy Clin Immunol. 2003; 112: 653-666
        • Nishinakamura R.
        • Nakayama N.
        • Hirabayashi Y.
        • Inoue T.
        • Aud D.
        • McNeil T.
        • et al.
        Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal.
        Immunity. 1995; 2: 211-222
        • Ogilvy S.
        • Metcalf D.
        • Gibson L.
        • Bath M.L.
        • Harris A.W.
        • Adams J.M.
        Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.
        Blood. 1999; 94: 1855-1863
        • Owen J.L.
        • Vakharia P.P.
        • Silverberg J.I.
        The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis.
        Am J Clin Dermatol. 2018; 19: 293-302
        • Panousis C.
        • Dhagat U.
        • Edwards K.M.
        • Rayzman V.
        • Hardy M.P.
        • Braley H.
        • et al.
        CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.
        MAbs. 2016; 8: 436-453
        • Pastore S.
        • Fanales-Belasio E.
        • Albanesi C.
        • Chinni L.M.
        • Giannetti A.
        • Girolomoni G.
        Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.
        J Clin Invest. 1997; 99: 3009-3017
        • Rossjohn J.
        • McKinstry W.J.
        • Woodcock J.M.
        • McClure B.J.
        • Hercus T.R.
        • Parker M.W.
        • et al.
        Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common beta-chain bound to an antagonist.
        Blood. 2000; 95: 2491-2498
        • Scott C.L.
        • Robb L.
        • Papaevangeliou B.
        • Mansfield R.
        • Nicola N.A.
        • Begley C.G.
        Reassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factor.
        Blood. 2000; 96: 1588-1590
        • Siracusa M.C.
        • Saenz S.A.
        • Hill D.A.
        • Kim B.S.
        • Headley M.B.
        • Doering T.A.
        • et al.
        TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation.
        Nature. 2011; 477: 229-233
        • Stomski F.C.
        • Sun Q.
        • Bagley C.J.
        • Woodcock J.
        • Goodall G.
        • Andrews R.K.
        • et al.
        Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.
        Mol Cell Biol. 1996; 16: 3035-3046
        • Sun Q.
        • Jones K.
        • McClure B.
        • Cambareri B.
        • Zacharakis B.
        • Iversen P.O.
        • et al.
        Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors.
        Blood. 1999; 94: 1943-1951
        • Taha R.A.
        • Leung D.Y.
        • Ghaffar O.
        • Boguniewicz M.
        • Hamid Q.
        In vivo expression of cytokine receptor mRNA in atopic dermatitis.
        J Allergy Clin Immunol. 1998; 102: 245-250
        • Vocanson M.
        • Hennino A.
        • Rozières A.
        • Poyet G.
        • Nicolas J.F.
        Effector and regulatory mechanisms in allergic contact dermatitis.
        Allergy. 2009; 64: 1699-1714
        • Wang B.
        • Esche C.
        • Mamelak A.
        • Freed I.
        • Watanabe H.
        • Sauder D.N.
        Cytokine knockouts in contact hypersensitivity research.
        Cytokine Growth Factor Rev. 2003; 14: 381-389
        • Woodcock J.M.
        • Bagley C.J.
        • Zacharakis B.
        • Lopez A.F.
        A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands.
        J Biol Chem. 1996; 271: 25999-26006
        • Woodcock J.M.
        • Zacharakis B.
        • Plaetinck G.
        • Bagley C.J.
        • Qiyu S.
        • Hercus T.R.
        • et al.
        Three residues in the common beta chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF.
        EMBO J. 1994; 13: 5176-5185
        • Yamamoto N.
        • Sugiura H.
        • Tanaka K.
        • Uehara M.
        Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels.
        J Dermatol Sci. 2003; 33: 121-126
        • Yang Y.C.
        • Ciarletta A.B.
        • Temple P.A.
        • Chung M.P.
        • Kovacic S.
        • Witek-Giannotti J.S.
        • et al.
        Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.
        Cell. 1986; 47: 3-10
        • Yip K.H.
        • Wilson N.J.
        • Pant H.
        • Brown C.L.
        • Busfield S.
        • Ng M.
        • et al.
        Anti-βc mAb CSL311 inhibits human nasal polyp pathophysiology in a humanized mouse xenograft model [published correction appears in Allergy 2021;76:1945].
        Allergy. 2020; 75: 475-478